Skip to main content

Day: April 16, 2026

Kingstone Schedules First Quarter 2026 Earnings Release and Conference Call

KINGSTON, N.Y., April 16, 2026 (GLOBE NEWSWIRE) — Kingstone Companies, Inc. (Nasdaq: KINS) (the “Company” or “Kingstone”), a property and casualty insurance holding company, today announced that it will issue financial results for the first quarter ended March 31, 2026, after the market closes on Thursday, May 7, 2026. Management will host a conference call to discuss the Company’s business operations and financial results at 8:30am ET on Friday, May 8, 2026. Participants are asked to dial-in approximately 10 minutes before the conference call is scheduled to begin by dialing: U.S toll-free: 1-877-407-2991International: 1-201-389-0925 A webcast of the live call will be available in the “Investor Relations” section of the Company’s website at www.kingstonecompanies.com or by clicking here. A replay of the...

Continue reading

Chicago Atlantic Real Estate Finance Schedules First Quarter 2026 Earnings Release and Conference Call Date

CHICAGO, April 16, 2026 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial mortgage real estate investment trust, announced details for the release of its results for the first quarter ended March 31, 2026. The Company plans to issue its earnings release and supplemental financial information before the market opens on Thursday, May 7, 2026. Chicago Atlantic will host a conference call and live audio webcast, both open for the general public to hear, later that day at 9:00 a.m. Eastern Time. The number to call for this interactive teleconference is (833) 630-1956 (international callers: 412-317-1837). The live audio webcast of the Company’s quarterly conference call will be available online in the Investor Relations section of the Company’s...

Continue reading

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases, today announced the closing of its previously announced underwritten public offering of 7,475,000 shares of its common stock, including the full exercise of the underwriters’ option to purchase up to 975,000 additional shares, at a public offering price per share of $62.00. The gross proceeds to Spyre from the offering were approximately $463.5 million before deducting underwriting discounts and commissions and other offering expenses payable by Spyre. Jefferies LLC, Goldman Sachs & Co. LLC, Evercore ISI, and Guggenheim...

Continue reading

Kite Realty Group Elevates Platform with Senior Leadership Appointments

INDIANAPOLIS, April 16, 2026 (GLOBE NEWSWIRE) — Kite Realty Group (NYSE: KRG) (“KRG” or the “Company”) today announced a deepening of its leadership team across operations, technology and finance – a direct investment in platform capabilities to sustain execution intensity and accelerate long-term value creation. Just as KRG has been systematically strengthening its portfolio through disciplined capital recycling, today’s appointments reflect that same intentional approach applied internally – adding proven talent in areas central to the Company’s multi-year growth strategy.Sean Daly has joined as Senior Vice President, Asset & Property Management. Mr. Daly brings more than two decades of experience across asset management, leasing, and development, most recently as Executive Vice President of Asset Management at American...

Continue reading

Trupanion Announces First Quarter 2026 Earnings Release and Conference Call

SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) — Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 first quarter after the market closes on Thursday, April 30, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion’s Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can access the conference call by dialing 1-844-676-1342 (United States) or 1-412-634-6683 (International). A telephonic replay of the call will...

Continue reading

Martin Marietta Announces First-Quarter 2026 Earnings Conference Call

RALEIGH, N.C., April 16, 2026 (GLOBE NEWSWIRE) — Martin Marietta Materials, Inc. (NYSE: MLM) (Martin Marietta or the Company) will host its first-quarter 2026 earnings call on Thursday, April 30, 2026, at 10:00 a.m. Eastern Time. The Company will release results for the quarter ended March 31, 2026, that morning before the market opens. A live, listen-only webcast and supplemental information will be accessible on the Investors section of the Company’s website at www.martinmarietta.com. The conference call may also be accessed by dialing +1 (646) 307-1963 and using conference ID 6288728. Please dial in at least 15 minutes in advance to ensure a timely connection. An on-demand replay will be available on the Company’s website approximately two hours following the conclusion of the live broadcast and will be available for one year. Martin...

Continue reading

Inseego Corp. to Report First Quarter 2026 Financial Results on May 7, 2026

SAN DIEGO, April 16, 2026 (GLOBE NEWSWIRE) — Inseego Corp. (Nasdaq: INSG) (the “Company”), a global leader in 5G mobile broadband and 5G fixed wireless access (FWA) solutions, today announced that the Company will release its financial results for the first quarter of 2026, ended March 31, 2026, after the financial markets close on May 7, 2026. The financial statements and earnings press release will be made available at investor.inseego.com and will be filed under Inseego’s profile on EDGAR at www.sec.gov. The Company will host a conference call that same day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss its results and business outlook. A live audio webcast of the conference call will be accessible from the “Investor relations” section of the Company’s website at investor.inseego.com. To access...

Continue reading

Lakeland Fire + Safety Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Q4 FY26 Net Sales of $45.8 Million; FY26 Net Sales Increased 15% to $192.6 Million Driven by 49% Growth in Fire Services Delivers Operating Cash Flow in Q4 FY26, Demonstrating Improved Operating Discipline Completed Divestiture of HPFR and HiViz Product Lines for Approximately $14 Million in Cash Proceeds in March 2026 Received All NFPA 1970 Certifications for Head-to-Toe Fire Portfolio Enabling Customers to Commence Purchase Orders New Certified Products and Expanded PPE Options to be Showcased at FDIC 2026 in April Company Repositioning with New Leadership Enhances Operating Discipline and Visibility to Support More Consistent Margins, Inventory Efficiency, and Cash Flow in FY2027 Targets High Single-Digit Revenue Growth & Positive Cash Flow from Operations in FY 2027 Management to Host Conference Call Today at 4:30 p.m. Eastern...

Continue reading

Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse

RICHMOND, Va., April 16, 2026 (GLOBE NEWSWIRE) — Indivior PLC (Nasdaq: INDV) today announced results from a national survey published in the Journal of Correctional Health Care showing that correctional leaders identify staffing and coordination gaps as key barriers to reducing diversion of medications for opioid use disorder (MOUD) and recognized long-acting injectable (LAI) buprenorphine as a strategy to help mitigate diversion and improve treatment in jail and prison settings. The cross-sectional survey included responses from 180 correctional professionals across U.S. jail and prison facilities. Among respondents, a strong majority — 88% of those working in jails and 87% in prisons — reported that LAI buprenorphine could help reduce MOUD diversion within their facilities. “As national policy attention turns toward strengthening...

Continue reading

AM Best Upgrades SiriusPoint’s Operating Subsidiaries to ‘A’ (Excellent)

HAMILTON, Bermuda, April 16, 2026 (GLOBE NEWSWIRE) — AM Best has upgraded the Financial Strength Rating to A (Excellent) from A- (Excellent), the Long-Term Issuer Credit Ratings (“ICR”) to “a” (Excellent) from “a-” (Excellent), and the Long-Term ICR to “bbb” (Good) from “bbb-” (Good) of SiriusPoint and its operating subsidiaries (“SiriusPoint” or the “Company”). The outlook of these ratings is stable.   These ratings reflect SiriusPoint’s consolidated balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management. The upgrade comes two months after Fitch Ratings upgraded its Insurer Financial Strength rating of SiriusPoint’s operating subsidiaries to ‘A’ (Strong) from ‘A-‘. AM Best cited SiriusPoint’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.